🇺🇸 FDA
Pipeline program

89Zr-trastuzumab

14-156

Unknown other completed

Quick answer

89Zr-trastuzumab for Breast Cancer Metastases is a Unknown program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Breast Cancer Metastases
Phase
Unknown
Modality
other
Status
completed

Clinical trials